Search This Blog

Tuesday, November 6, 2018

Spark Therapeutics reports Q3 EPS ($1.26), consensus (98c)


Reports Q3 revenue $10.7M, consensus $26.22M.
https://thefly.com/landingPageNews.php?id=2818259
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)